Characterization of signal transduction and glucose transport in skeletal muscle from type 2 diabetic patients

Diabetes

Volumn 49, Issue 2, 2000, Pages 284-292

  Krook, Anna ^a,b   Björnholm, Marie ^a,b   Galuska, Dana ^a,b   Jiang, Xin Jian ^a   Fahlman, Roger ^a   Myers Jr , Martin G ^c   Wallberg Henriksson, Harriet ^a,b   Zierath, Juleen R ^a,b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c JOSLIN DIABETES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOGEN SYNTHASE; INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; GLUCOSE TRANSPORT; HUMAN; MALE; MITOGENESIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SKELETAL MUSCLE;

EID: 0343314906     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.49.2.284     Document Type: Article

References (59)

1. DeFronzo RA, Jocot E, Jequier E, Maeder E, Wahren J, Felber JP: The effect of insulin on the disposal of intravenous glucose. Diabetes 30:1000-1007, 1981
2. DeFronzo RA, Gunnarsson R, Björkman O, Olsson M, Wahren J: Effects of insulin on peripheral and splanchnic glucose metabolism in non-insulin-dependent (Type II) diabetes mellitus. J Clin Invest 76:149-155, 1985
3. Vaag A, Henriksen JE, Beck-Nielsen H: Decreased insulin activation of glycogen synthase in skeletal muscle in young nonobese Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus. J Clin Invest 89:782-788, 1992
4. Andréasson K, Galuska D, Thörne A, Sonnenfeld T, Wallberg-Henriksson H: Decreased insulin-stimulated 3-O-methylglucose transport in in vitro incubated muscle strips from type II diabetic subjects. Acta Physiol Scand 142:255-260, 1991
5. Zierath JR, Galuska D, Nolte LA, Thörne A, Smedegaard-Kristensen J, Wallberg-Henriksson H: Effects of glycaemia on glucose transport in isolated skeletal muscle from patients with NIDDM: in vitro reversal of muscular insulin resistance. Diabetologia 37:270-277, 1994
6. Bonadonna RC, Del Prato S, Bonora E, Saccomani MP, Gulli G, Natali A, Frascerra, S, Pecori N, Ferrannini E, Bier D, Cobelli C, DeFronzo RA: Roles of glucose transport and glucose phosphorylation in muscle insulin resistance of NIDDM. Diabetes 45:915-925, 1996
7. Dohm GL, Tapscott EB, Pories WJ, Dabbs DJ, Flickinger EG, Meelheim D, Fushiki T, Atkinson SM, Elton CW, Caro JF: An in vitro human skeletal muscle preparation suitable for metabolic studies: decreased insulin stimulation of glucose transport in muscle from morbidly obese and diabetic subjects. J Clin Invest 82:486-494, 1988
8. Kelley DE, Mintun MA, Watkins SC, Simoneau J-A, Jadali F, Fredrickson A, Beattie J, Thériault R: The effect of non-insulin-dependent diabetes mellitus and obesity on glucose transport and phosphorylation in skeletal muscle. J Clin Invest 97:2705-2713, 1996
9. 31P nuclear magnetic resonance measurements of muscle glucose-6-phosphate: evidence for reduced insulin-dependent muscle glucose transport or phosphorylation activity in non-insulin-dependent diabetes mellitus. J Clin Invest 89:1062-1075, 1992
10. Marette A, Burdett E, Douen A, Vranic M, Klip A: Insulin induces the translocation of the GLUT4 from a unique intracellular organelle to the transverse tubules in rat skeletal muscle. Diabetes 41:1562-1569, 1992
11. Munoz P, Rosenblatt M, Testar X, Palacin M, Thoidis G, Pilch PF, Zorzano A: The t-tubule is a cell-surface target for insulin-regulated recycling of membrane proteins in skeletal muscle. Biochem J 312:393-400, 1995
12. Ploug T, van Deurs B, Ai H, Cushman SW, Ralston E: Analysis of GLUT4 distribution in whole skeletal muscle fibers: identification of distinct storage compartments that are reduced by insulin and muscle contractions. J Cell Biol 142:1429-1446, 1998
13. Björnholm M, Kawano Y, Lehtihet M, Zierath JR: Insulin receptor substrate-1 phosphorylation and phosphatidylinositol 3-kinase activity in skeletal muscle from NIDDM subjects after in vivo insulin stimulation. Diabetes 46:524-527, 1997
14. Krook A, Roth RA, Jiang XJ, Zierath JR, Wallberg-Henriksson H: Insulin-stimulated Akt kinase activity is reduced in skeletal muscle from non-insulin-dependent diabetic subjects. Diabetes 47:1281-1286, 1998
15. Zierath JR, He L, Gumá A, Odegaard-Wahlström E, Klip A, Wallberg-Henriksson H: Insulin action on glucose transport and plasma membrane content in skeletal muscle from patients with NIDDM. Diabetologia 39:1180-1189, 1996
16. Garvey WT, Maianu L, Zhu JH, Brechtel-Hook G, Wallace P, Baron AD: Evidence for defects in the trafficking and translocation of GLUT4 glucose transporters in skeletal muscle as a cause of human insulin resistance. J Clin Invest 101:2377-2386, 1988
17. Virkamäki A, Ueki K, Kahn CR: Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance. J Clin Invest 103:931-943, 1999
18. Sun XJ, Rothenberg P, Kahn CR, Backer JM, Araki E, Wilden PA, Cahill DA, Goldstein BJ, White MF: Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein. Nature 352:73-77, 1991
19. Sun XJ, Wang LM, Zhang Y, Yenush L, Myers MG Jr, Glasheen E, Lane WS, Pierce JH, White MF: Role of IRS-2 in insulin and cytokine signalling. Nature 377:173-177, 1995
20. Lavan BE, Fantin VR, Chang ET, Lane WS, Keller SR, Lienhard GE: A novel 160-kDa phosphotyrosine protein in insulin-treated embryonic kidney cells is a new member of the insulin receptor substrate family. J Biol Chem 272:21403-21407, 1997
21. Lavan BE, Lane WS, Lienhard GE: The 60-kDa phosphotyrosine protein in insulin-treated adipocytes is a new member of the insulin receptor substrate family. J Biol Chem 272:11439-11443, 1997
22. Okada T, Kawano Y, Sakakibara T, Hazeki O, Ui M: Essential role of phosphatidylinositol 3-kinase in insulin-stimulated glucose transport and antilipolysis in rat adipocytes: studies with a selective inhibitor wortmannin. J Biol Chem 260:3568-3573, 1994
23. Saad MJA, Araki E, Miralpeix M, Rothenberg PL, White MF, Kahn CR: Regulation of insulin receptor substrate-1 in liver and muscle of animal models of insulin resistance. J Clin Invest 90:1839-1849, 1992
24. Folli F, Saad MJA, Backer JM, Kahn CR: Regulation of phosphatidylinositol 3-kinase activity in liver and muscle of animal models of insulin-resistant and insulin-deficient diabetes mellitus. J Clin Invest 92:1787-1794, 1993
25. Saad MJA, Folli F, Kahn JA, Kahn CR: Modulation of insulin receptor, insulin receptor substrate-1, and phosphatidylinositol 3-kinase in liver and muscle of dexamethasone-treated rats. J Clin Invest 92:2065-2072, 1993
26. Heydrick SJ, Jullien D, Gautier N, Tanti JF, Giorgetti S, Van Obberghen E, Marchand-Brustel Y: Defect in skeletal muscle phosphatidylinositol-3-kinase in obese insulin-resistant mice. J Clin Invest 91:1358-1366, 1993
27. DeFronzo RA, Tobin JD, Anders R: Glucose clamp technique: a model for quantifying insulin secretion and resistance. Am J Physiol 237:E214-E223, 1979
28. Miles J, Glasscock R, Aikens J, Gerich J, Raymond M: A microfluorometric method for the determination of free fatty acid in plasma. J Lipid Res 24:96-99, 1983
29. Wallberg-Henriksson H, Gunnarsson R, Henriksson J, Östman J, Wahren J: Influence of physical training on formation of muscle capillaries in type I diabetes. Diabetes 33:851-857, 1984
30. Mazess RB, Barden HS, Bisek JP, Hanson J: Dual-energy x-ray absorptiometry for total-body and regional bone-mineral and soft-tissue composition. Am J Clin Nutr 51:1106-1112, 1990
31. Hjeltnes N, Aksnes AK, Birkeland KI, Johansen J, Lannem A, Wallberg-Henriksson H: Improved body composition after 8 wk of electrically stimulated leg cycling in tetraplegic patients. Am J Physiol 273:R1072-R1079, 1997
32. Zierath JR: In vitro studies of human skeletal muscle: hormonal and metabolic regulation of glucose transport. Acta Physiol Scand 626:1-96, 1995
33. Wallberg-Henriksson H, Zetan N, Henriksson J: Reversibility of decreased insulin-stimulated glucose transport capacity in diabetic muscle with in vitro incubation: insulin is not required. J Biol Chem 262:7665-7671, 1987
34. Krook A, Whitehead JP, Dobson SP, Griffiths MR, Ouwens M, Baker C, Hayward AC, Sen SK, Maassen JA, Siddle K, Tavare JM, O'Rahilly S: Two naturally occurring insulin receptor tyrosine kinase domain mutants provide evidence that phosphatidylinositol 3-kinase activation alone is not sufficient for the meditation of insulin's metabolic and mitogenic effects. J Biol Chem 272:30208-30214, 1997
35. Thomas JA, Schlender K, Larner J: A rapid filter paper assay for UDPglucose-glycogen glucosyltransferase, including an improved biosynthesis of UDP-14C-glucose. Anal Biochem 25:486-499, 1968
36. Caro JF, Sinha MK, Raju SM, Ittoop O, Pories WJ, Flickinger EG, Meelheim D, Dohm GL: Insulin receptor kinase in human skeletal muscle from obese subjects with and without non-insulin dependent diabetes. J Clin Invest 79:1330-1337, 1987
37. Klein HH, Vestergaard H, Kotzke G, Pedersen O: Elevation of serum insulin concentration during euglycemic-hyperinsulinemic clamp studies leads to similar activation of insulin receptor kinase in skeletal muscle of subjects with and without NIDDM. Diabetes 44:1310-1317, 1995
38. Arner P, Pollare T, Lithell H, Livingston JN: Defective insulin receptor tyrosine kinase in human skeletal muscle in obesity and type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 30:437-440, 1987
39. Nolan JJ, Freidenberg G, Henery R, Reichart D, Olefsky JM: Role of human skeletal muscle insulin receptor kinase in the in vivo insulin resistance of non-insulin-dependent diabetes mellitus and obesity. J Clin Endocrinol Metab 78:471-477, 1994
40. Maegawa H, Shigeta Y, Egawa K, Kobayashi M: Impaired autophosphorylation of insulin receptors from abdominal skeletal muscles in non-obese subjects with NIDDM. Diabetes 40:815-819, 1991
41. Manson JE, Spelsberg A: Reduction in risk factors of coronary heart disease and diabetes. In The Health Professionals Guide to Diabetes and Exercise. Ruderman N, Devlin JT, Eds. Alexandria, VA, American Diabetes Association, 1995, p. 51-58
42. Goodyear LJ, Giorgino F, Sherman LA, Carey J, Smith RJ, Dohm GL: Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese subjects. J Clin Invest 95:2195-2204, 1995
43. Utriainen T, Nuutila P, Takala T, Vicini P, Ruotsalainen U, Ronnemaa T, Tolvanen T, Raitakari M, Haaparanta M, Kirvela O, Cobelli C, Yki-Jarvinen H: Intact insulin stimulation of skeletal muscle blood flow, its heterogeneity and redistribution, but not of glucose uptake in non-insulin-dependent diabetes mellitus. J Clin Invest 100:777-785, 1997
44. Pillay TS, Xiao S, Olefsky JM: Glucose-induced phosphorylation on the insulin receptor. J Clin Invest 97:613-620, 1996
45. Kroder G, Bossenmaier B, Kellerer M, Capp E, Stoyanov B, Mühlhöfer A, Berti L, Horikoshi H, Ullrich A, Häring H: Tumor necrosis factor-α- and hyperglycemia-induced insulin resistance: evidence for different mechanisms and different effects on insulin signaling. J Clin Invest 97:1471-1477, 1995
46. Dresner A, Laurent D, Marcucci M, Griffin ME, Dufour S, Cline GW, Slezak LA, Andersen DK, Hundal RS, Rothman DL, Petersen KF, Schulman GI: Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. J Clin Invest 103:253-259, 1999
47. Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, Spiegelman BM: IRS-1 mediated inhibition of insulin receptor tyrosine kinase activity in TNF-α- and obesity-induced insulin resistance. Science 271:665-668, 1996
48. Tanti JF, Gremeaux T, Van Obberghen E, Le Marchand-Brustel Y: Serine/threonine phosphorylation of insulin receptor substrate 1 modulates insulin receptor signaling. J Biol Chem 269:6051-6057, 1994
49. De Fea K, Roth RA: Protein kinase C modulation of insulin receptor substrate-1 tyrosine phosphorylation requires serine 612. Biochemistry 36:12939-12947, 1997
50. Qiao L, Goldberg JL, Russell JC, Sun XJ: Identification of enhanced serine kinase activity in insulin resistance. J Biol Chem 274:10625-10632, 1999
51. Damsbo P, Vaag A, Hother-Nielsen O, Beck-Nielsen H: Reduced glycogen synthase activity in skeletal muscle from obese patients with and without type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 34:239-245, 1991
52. Dela F, Larsen JJ, Mikines KJ, Ploug T, Petersen LN, Galbo H: Insulin-stimulated muscle glucose clearance in patients with NIDDM: effects of one-legged physical training. Diabetes 44:1010-1020, 1995
53. Vaag A, Damsbo P, Hother-Nielsen O, Beck-Nielsen H: Hyperglycaemia compensates for the defects in insulin-mediated glucose metabolism and in the activation of glycogen synthase in the skeletal muscle of patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 35:80-88, 1992
54. Shulman GI, Rothman DL, Jue T, Stein P, DeFronzo RA, Shulman RG: Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy. N Engl J Med 322:223-228, 1990
55. Thorburn AW, Gumbiner B, Bulacan F, Brechtel G, Henry RR: Multiple defects in muscle glycogen synthase activity contribute to reduced glycogen synthesis in non-insulin dependent diabetes mellitus. J Clin Invest 87:489-495, 1991
56. Vestergaard H, Lund S, Larsen FS, Bjerrum OJ, Pedersen O: Glycogen synthase and phosphofructokinase protein and mRNA levels in skeletal muscle from insulin-resistant patients with non-insulin-dependent diabetes mellitus. J Clin Invest 91:2342-2350, 1993
57. Vestergaard H, Bjorbaek C, Andersen PH, Bak JF, Pedersen O: Impaired expression of glycogen synthase mRNA in skeletal muscle of NIDDM patients. Diabetes 40:1740-1745, 1991
58. Inoue G, Cheatham B, Emkey R, Kahn CR: Dynamics of insulin signaling in 3T3-L1 adipocytes: differential compartmentalization and trafficking of insulin receptor substrate (IRS)-1 and IRS-2. J Biol Chem 273:11548-11555, 1998
59. Clark SF, Martin S, Carozzi AJ, Hill MM, James DE: Intracellular localization of phosphatidylinositide 3-kinase and insulin receptor substrate-1 in adipocytes: potential involvement of a membrane skeleton. J Cell Biol 140: 1211-1225, 1998